For example, patients with metabolic syndrome, a condition characterized by insulin resistance, obesity, and dyslipidemia, may be particularly vulnerable to the negative effects of TCAs on adiponectin levels. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.